Author: Abdallah el-Kurebe

As we match towards 2024 and beyond with political baggage, uncertainties, and a frustrating national economy, it appears that the only goldmine every Nigerian should be considering and preparing themselves for is the diversion of their interests to agriculture. This is the reason why the Nigerian government should create an environment conducive for commercial agriculture.

Read More

The Immunoadoptive Cell Therapy Private Limited (ImmunoACT), based in Mumbai, India, on October 13, 2023, announced the Central Drugs Standard Control Organization (CDSCO)’s approval for the use of the country’s first chimeric antigen receptor (CAR-T) cell therapy for the treating relapsed-refractory B-cell lymphoma and leukemia.

Read More